Friday, June 8, 2012

KV Pharma ($KV) Announces Entry into a Material Definitive Agreement, Unregistered Sale of Equity

From an 8-K that was just filed:

"K-V Pharmaceutical Company (the “Company” or “we”) entered into a Common Stock Purchase Agreement dated as of June 5, 2012 (the “Purchase Agreement”), with Commerce Court Small Cap Value Fund, Ltd. (“Commerce Court”), pursuant to which we may, subject to certain customary conditions, require Commerce Court to purchase up to $20.0 million of shares of our Class A Common Stock over the 24-month term following the effectiveness of the resale registration statement described below. Such arrangement is sometimes referred to as a 'committed equity line financing facility.'

From time to time over the 24-month term, and in our sole discretion, we may present Commerce Court with draw down notices requiring Commerce Court to purchase a specified dollar amount of shares of our Class A Common Stock, based on the price per share per day over 10 consecutive trading days (the “Draw Down Period”), with the total dollar amount of each draw down subject to certain agreed-upon limitations based on the market price of our Class A Common Stock at the time of the draw down. We will not issue or sell under the Purchase Agreement a number of shares of our Class A Common Stock (including the shares issuable to Commerce Court as consideration for its commitment to enter into the Purchase Agreement as described below) that, when aggregated with any shares of our Class A Common Stock or Class B Common Stock issued or issuable to Commerce Court pursuant to any transaction that would be aggregated with such sale under applicable rules of the New York Stock Exchange (the “NYSE”), would exceed that number of shares which is one less than 20% of the aggregate number of shares of Class A Common Stock and Class B Common Stock issued and outstanding on the date immediately prior to the earliest of such issuance or sale, unless approval of our stockholders is obtained under applicable rules of the NYSE prior to any issuance or sale of shares of our Class A Common Stock in excess of such amount. In addition, in our sole discretion, but subject to certain limitations, we may require Commerce Court to purchase a percentage of the daily trading volume of our Class A Common Stock for each trading day during the Draw Down Period. We are allowed to present Commerce Court with up to 24 draw down notices during the 24-month term, with only one such draw down notice allowed per Draw Down Period and a minimum of five trading days required between each Draw Down Period.

Once presented with a draw down notice, Commerce Court is required to purchase a pro-rata portion of the shares on each trading day during the trading period on which the daily volume weighted average price for our Class A Common Stock exceeds a threshold price determined solely by us for such draw down. The per share purchase price for these shares equals the daily volume weighted average price of our common stock on each date during the Draw Down Period on which shares are purchased, less a discount ranging from 6.00% to 8.00% based on a minimum price that we solely specify. If the daily volume weighted average price of our common stock falls below the threshold price on any trading day during a Draw Down Period, the Purchase Agreement provides that there will be no purchases or sales of the pro-rata portion of shares of Class A Common Stock allocated to that day. We have paid approximately $35,000 of Commerce Court’s legal fees and expenses. No additional legal fees incurred by Commerce Court are payable by us in connection with any sale of shares to Commerce Court.

In consideration for Commerce Court’s execution and delivery of the Purchase Agreement and upon the execution and delivery of the Purchase Agreement, we issued Commerce Court 200,000 shares of our Class A Common Stock, which we refer to as the “Commitment Shares.” The issuance of the Commitment Shares, together with all other shares of Class A Common Stock issuable to Commerce Court pursuant to the terms of the Purchase Agreement, is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of and Rule 506 of Regulation D under the Securities Act.

We have agreed to indemnify Commerce Court and its affiliates for losses related to a breach of the representations and warranties by the Company under the Purchase Agreement or the other transaction documents or any action instituted against Commerce Court or its affiliates due to the transactions contemplated by the Purchase Agreement or other transaction documents, subject to certain limitations. Commerce Court has agreed to indemnify us and our affiliates for losses under securities laws for any material omissions or misstatements with respect to information provided by Commerce Court for inclusion in the registration statement covering the resale by Commerce Court of shares sold to it under the Purchase Agreement, subject to certain limitations.
So, basically, they are going to be issuing $20 million in new stock, in dribs and drabs, at a discount to the market price. Not bullish for the equity. Potentially bullish for the debt, depending on how they use the proceeds. If the company was to issue this equity and start buying the notes that are putable next year, that would be ultra bullish for the long bonds short stock trade.

No comments: